Denali Therapeutics (NASDAQ:DNLI) Price Target Lowered to $28.00 at Bank of America
Denali Therapeutics (NASDAQ:DNLI – Get Free Report) had its target price reduced by Bank of America from $30.00 to $28.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Bank of America‘s target price indicates a potential upside of 86.17% from the stock’s current price. DNLI […]
Denali Therapeutics (NASDAQ:DNLI – Get Free Report) had its target price reduced by Bank of America from $30.00 to $28.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Bank of America‘s target price indicates a potential upside of 86.17% from the stock’s current price. DNLI […]
